Neuroprotection

Aims & Scope

Neuroprotection publishes work centred around the recent advances and breakthroughs in the fields of neuroprotection and central as well as peripheral nervous system repair.

This translational neuroscience journal spans fields including neurobiology, neuropharmacology, neurology, neurosurgery, neuroimaging, neurorehabilitation and basic, as well as translational, neuroscience.

We’re excited to contribute to the advancement of next-generation treatments for CNS disorders.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Neuroscience, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine and Neuroscience, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 3,000.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Glutamate and excitotoxicity in central nervous system disorders: ionotropic glutamate receptors as a target for neuroprotection

  Citation: 30

  Authors: Jorge Y., Christian

• Preserving cognitive function in patients with Alzheimer's disease: The Alzheimer's disease neuroprotection research initiative (ADNRI)

  Citation: 17

  Authors: Jie, Heleen, Xian‐Le, Gong, Paulo, Xiaochun, Xiaowei, Andrew N., Tracy D., Yuhong, Jianping, Jukka, Woojin Scott, Paula, Shen, Yajie, Guang‐Hui, Guiyou, Yu‐Hui, Tarja, Xiaobo, Joaquim Miguel, Mike M., Pedro, Karsten, Weihong, Jun, Xuanyue, Yun, Haitao, Lize, Yi, Keqiang, Jin‐Tai, Xin‐Fu, Marietta, Colin L., Piotr, Johannes, Xunming, Yan‐Jiang

• Mesenchymal stem cell‐derived exosomes: Shaping the next era of stroke treatment

  Citation: 17

  Authors: Arshi, Rizwanul, Miroslaw, Syed S.

• The dual role of microglia in ischemic stroke and its modulation via extracellular vesicles and stem cells

  Citation: 13

  Authors: Matteo, Stefan T., Thorsten R.

• Exploiting moderate hypoxia to benefit patients with brain disease: Molecular mechanisms and translational research in progress

  Citation: 11

  Authors: Hannelore, Max, Luise, Martin, Peter, Anna‐Leena, Klaus‐Armin, Kamilla

• Targeting brain‐derived neurotrophic factor in the treatment of neurodegenerative diseases: A review

  Citation: 10

  Authors: Dong, Zhi‐Chen, Shi‐Nan, Wei, Hao

• Research progress on intranasal treatment for Parkinson's disease

  Citation: 9

  Authors: Puyuan, Chao

• Tolerability and first hints for potential efficacy of motor‐cognitive training under inspiratory hypoxia in health and neuropsychiatric disorders: A translational viewpoint

  Citation: 6

  Authors: Svea‐Solveig, Maren, Martin, Justus B. H., Roman, Umer Javed, Jonathan‐Alexis, Umut, Marie, Markus, Vinicius Daguano, Johannes, Julie, Matthias, Martin, Andreas, Luise, Peter, Markus, Fred, Manvendra, Klaus‐Armin, Kamilla Woznica, Hannelore

• Mechanisms of glutamate metabolic function and dysfunction in vascular dementia

  Citation: 5

  Authors: Jiawen, Yingmei, Ning, Dongshan, Jiaxin, Yanlin, Xiaoxia, Xiaohui, Bin, Qinghua, Rujia

• Microglial senescence in neurodegeneration: Insights, implications, and therapeutic opportunities

  Citation: 5

  Authors: Tobiloba Samuel, Toheeb O., Omolabake I., Oritoke M., Olayemi J., Omamuyouwi M.